Silencing Palestinian voices: On freedom of expression and Gaza
Netherlands Quarterly of Human Rights · 2025-03 · 43 (1) · 3-11
DOI: 10.1177/09240519251325419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Netherlands Quarterly of Human Rights, online erschienen am 28.03.2025. Verfasst von Stefania Di Stefano. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The right to freedom of expression is currently facing a global crisis unleashed by the conflict in Gaza. The conflict has led to a high polarisation of public opinion, with opposing factions supporting either Israel's actions or the Palestinian cause. Yet, the right to freedom of expression of Palestinian activists and their supporters is facing systematic suppression worldwide. In this column, I shed light on how state and non-state actors have been active vehicles for the restriction of the right to freedom of expression by targeting voices in support of the Palestinian cause and I consider the application and scope of the right to freedom of expression in this context. The column concludes that the failure to protect the right of Palestinians to have their voices heard contributes to the erosion of our collective right to freedom of expression and has wider repercussion on the promotion and protection of human rights more generally.
Zitieren
APA
Stefano, S. D. (2025). Silencing Palestinian voices: On freedom of expression and Gaza. Netherlands Quarterly of Human Rights, 43(1), 3-11. https://doi.org/10.1177/09240519251325419
Vancouver
Stefano SD. Silencing Palestinian voices: On freedom of expression and Gaza. Netherlands Quarterly of Human Rights. 2025;43(1):3-11. doi:10.1177/09240519251325419
BibTeX
@article{Stefano2025,
author = {Stefano, Stefania Di},
title = {Silencing Palestinian voices: On freedom of expression and Gaza},
journal = {Netherlands Quarterly of Human Rights},
year = {2025},
volume = {43},
number = {1},
pages = {3--11},
doi = {10.1177/09240519251325419}
}
EUVIMED